H. Lundbeck, announces license agreement and equity investment in Warren Pharmaceuticals

H. Lundbeck A/S has licensed certain rights to Warren Pharmaceuticals’ proprietary tissue protective technology. Lundbeck and BankInvest Biomedical Venture have each invested five million USD in Warren Pharmaceuticals, Inc., a privately held biotechnology company in Westchester County, New York.